BREAKING REPORT from John Hopkins Journal: GREAT NEWS on Hydroxychloroquine + Zinc

US MEDIA HAS BLOOD on their HANDS as well as Dr. FRAUDCHI

Hydroxychloroquine+azithromycin has been widely misrepresented in both clinical reports and public media, and outpatient trials results are not expected until September. Early outpatient illness is very different than later hospitalized florid disease and the treatments differ. Evidence about use of hydroxychloroquine alone, or of hydroxychloroquine+azithromycin in inpatients, is irrelevant concerning efficacy of the pair in early high-risk outpatient disease. Five studies, including two controlled clinical trials, have demonstrated significant major outpatient treatment efficacy. Hydroxychloroquine+azithromycin has been used as standard-of-care in more than 300,000 older adults with multicomorbidities, with estimated proportion diagnosed with cardiac arrhythmias attributable to the medications 47/100,000 users, of which estimated mortality is <20%, 9/100,000 users, compared to the 10,000 Americans now dying each week. These medications need to be widely available and promoted immediately for physicians to prescribe.

 

Supplementary data

WE NEED YOUR HELP
We are committed to keeping our content free and independent, which means no paywalls, no sponsored posts, no annoying product promotions or subscription fees.

If you like our content, and would like to help, please Like and share on social media and consider making a contribution:

Donate to TheWatchTowers - AN INDEPENDENT FREE PRESS.

Donate to TheWatchTowers – AN INDEPENDENT FREE PRESS.

TheWatchTowers.org
Translate »